Brickell launches first phase of gel study
BOULDER — Brickell Biotech Inc., a pharmaceutical company developing treatments for skin conditions, is partnering with Kaken Pharmaceutical Co. Ltd. […]
Source: BizWest
Related Articles
BizWest celebrates 40 years covering business and recognizes 40 iconic leaders who inspired the region’s development.
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
Biotechnology boom
The COVID-19 pandemic — and its seemingly never-ending aftermath — has been a nightmare for commercial landlords of many different…
Brickell Biotech launches brand reset amid positioning pivot
BOULDER — Brickell Biotech Inc. (Nasdaq: BBI), a clinical-stage pharmaceutical company, has launched a new brand, logo and website as…
Flatiron Park’s next phase
BOULDER — So, it’s early 2022, COVID-19 is wreaking havoc on the market for office space, and you’ve just made…
Fresh Tracks Therapeutics improves revenue, decreases loss during ‘transformational’ quarter
BOULDER — Fresh Tracks Therapeutics Inc. (Nasdaq: FRTX), the Boulder-based pharmaceutical company formerly called Brickell Biotech, saw both its top…